The original sins of clinical trials with intravenous immunoglobulins in sepsis
暂无分享,去创建一个
J. Eiros | J. Blanco | R. Almansa | E. Tamayo | D. Andaluz-Ojeda | J. Gómez-Herreras | L. Nogales | J. Bermejo-Martín
[1] J. Vincent,et al. Annual Update in Intensive Care and Emergency Medicine 2023 , 2014, Annual Update in Intensive Care and Emergency Medicine.
[2] R. Herrán-Monge,et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis , 2014, Journal of internal medicine.
[3] O. Liesenfeld,et al. Molecular diagnosis of sepsis: New aspects and recent developments. , 2014, European journal of microbiology & immunology.
[4] R. Herrán-Monge,et al. Circulating neutrophil counts and mortality in septic shock , 2014, Critical Care.
[5] L. Dans,et al. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. , 2013, The Cochrane database of systematic reviews.
[6] M. Dostál,et al. Presence of hypogammaglobulinemia - a risk factor of mortality in patients with severe sepsis, septic shock, and SIRS. , 2013, Prague medical report.
[7] M. Aman,et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. , 2012, The Journal of infectious diseases.
[8] M. Bianchi,et al. Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis. , 2012, Journal of critical care.
[9] M. Singer,et al. Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective , 2012, Critical Care.
[10] M. Päsler,et al. Hypogammaglobulinemia in Sepsis , 2012 .
[11] C. Malcus,et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. , 2011, International immunopharmacology.
[12] J. Eiros,et al. Early natural killer cell counts in blood predict mortality in severe sepsis , 2011, Critical care.
[13] J. Vincent,et al. &ggr;-GLOBULIN LEVELS IN PATIENTS WITH COMMUNITY-ACQUIRED SEPTIC SHOCK , 2009, Shock.
[14] A. Nierhaus,et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock * , 2007, Critical care medicine.
[15] R. Schmieder,et al. Score‐based immunoglobulin G therapy of patients with sepsis: The SBITS study * , 2007, Critical care medicine.
[16] L. Dans,et al. Intravenous immunoglobulin for treating sepsis and septic shock. , 2002, The Cochrane database of systematic reviews.